COCRYSTAL PHARMA, INC. Foreign Currency Transaction Gain (Loss), before Tax
COCRYSTAL PHARMA, INC. (COCP) reported Foreign Currency Transaction Gain (Loss), before Tax of $10.00 thousand for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Income Statement › Other Income
us-gaap:ForeignCurrencyTransactionGainLossBeforeTax · last filed 2026-08-13
- COCRYSTAL PHARMA, INC. foreign currency transaction gain (loss), before tax for the quarter ending 2026-06-30 was $10.00K, a 60.00% decline year-over-year.
- COCRYSTAL PHARMA, INC. foreign currency transaction gain (loss), before tax for the quarter ending 2026-03-31 was $35.00K, a 1066.67% increase year-over-year.
- COCRYSTAL PHARMA, INC. foreign currency transaction gain (loss), before tax for the quarter ending 2025-12-31 was $8.00K.
- COCRYSTAL PHARMA, INC. foreign currency transaction gain (loss), before tax for the quarter ending 2025-09-30 was $18.00K.
- COCRYSTAL PHARMA, INC. foreign currency transaction gain (loss), before tax for fiscal 2025 was $54.00K.
- COCRYSTAL PHARMA, INC. foreign currency transaction gain (loss), before tax for fiscal 2024 was -$163.00K.
- COCRYSTAL PHARMA, INC. foreign currency transaction gain (loss), before tax for fiscal 2023 was -$65.00K.
- COCRYSTAL PHARMA, INC. foreign currency transaction gain (loss), before tax for fiscal 2022 was -$18.00K.
| Period end | Foreign Currency Transaction Gain (Loss), before Tax 3 month | Foreign Currency Transaction Gain (Loss), before Tax 6 month | Foreign Currency Transaction Gain (Loss), before Tax 9 month | Foreign Currency Transaction Gain (Loss), before Tax 12 month |
|---|---|---|---|---|
| 2026-06-30 | $10.00K 10-Q · filed 2026-08-13 | $45.00K 10-Q · filed 2026-08-13 | $53.00K derived: sum of 3 quarters · filed 2026-08-13 | $71.00K derived: sum of 4 quarters · filed 2026-08-13 |
| 2026-03-31 | $35.00K 10-Q · filed 2026-05-15 | $43.00K derived: sum of 2 quarters · filed 2026-05-15 | $61.00K derived: sum of 3 quarters · filed 2026-05-15 | $86.00K derived: sum of 4 quarters · filed 2026-08-13 |
| 2025-12-31 | $8.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-31 | $26.00K derived: sum of 2 quarters · filed 2026-03-31 | $51.00K derived: sum of 3 quarters · filed 2026-08-13 | $54.00K 10-K · filed 2026-03-31 |
| 2025-09-30 | $18.00K 10-Q · filed 2025-11-14 | $43.00K derived: sum of 2 quarters · filed 2026-08-13 | $46.00K 10-Q · filed 2025-11-14 | -$45.00K derived: sum of 4 quarters · filed 2026-08-13 |
| 2025-06-30 | $25.00K 10-Q · filed 2026-08-13 | $28.00K 10-Q · filed 2026-08-13 | -$63.00K derived: sum of 3 quarters · filed 2026-08-13 | -$71.00K derived: sum of 4 quarters · filed 2026-08-13 |
| 2025-03-31 | $3.00K 10-Q · filed 2026-05-15 | -$88.00K derived: sum of 2 quarters · filed 2026-05-15 | -$96.00K derived: sum of 3 quarters · filed 2026-05-15 | -$142.00K derived: sum of 4 quarters · filed 2026-05-15 |
| 2024-12-31 | -$91.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-31 | -$99.00K derived: sum of 2 quarters · filed 2026-03-31 | -$145.00K derived: sum of 3 quarters · filed 2026-03-31 | -$163.00K 10-K · filed 2026-03-31 |
| 2024-09-30 | -$8.00K 10-Q · filed 2025-11-14 | -$54.00K derived: sum of 2 quarters · filed 2025-11-14 | -$72.00K 10-Q · filed 2025-11-14 | -$50.00K derived: sum of 4 quarters · filed 2025-11-14 |
| 2024-06-30 | -$46.00K 10-Q · filed 2025-08-14 | -$64.00K 10-Q · filed 2025-08-14 | -$42.00K derived: sum of 3 quarters · filed 2025-08-14 | -$84.00K derived: sum of 4 quarters · filed 2025-08-14 |
| 2024-03-31 | -$18.00K 10-Q · filed 2025-05-15 | $4.00K derived: sum of 2 quarters · filed 2025-05-15 | -$38.00K derived: sum of 3 quarters · filed 2025-05-15 | -$5.00K derived: sum of 4 quarters · filed 2025-05-15 |
| 2023-12-31 | $22.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-31 | -$20.00K derived: sum of 2 quarters · filed 2025-03-31 | $13.00K derived: sum of 3 quarters · filed 2025-03-31 | -$65.00K 10-K · filed 2025-03-31 |
| 2023-09-30 | -$42.00K 10-Q · filed 2024-11-13 | -$9.00K derived: sum of 2 quarters · filed 2024-11-13 | -$87.00K 10-Q · filed 2024-11-13 | -$86.00K derived: sum of 4 quarters · filed 2024-11-13 |
| 2023-06-30 | $33.00K 10-Q · filed 2024-08-14 | -$45.00K 10-Q · filed 2024-08-14 | -$44.00K derived: sum of 3 quarters · filed 2024-08-14 | -$49.00K derived: sum of 4 quarters · filed 2024-08-14 |
| 2023-03-31 | -$78.00K 10-Q · filed 2024-05-13 | -$77.00K derived: sum of 2 quarters · filed 2024-05-13 | -$82.00K derived: sum of 3 quarters · filed 2024-05-13 | -$83.00K derived: sum of 4 quarters · filed 2024-05-13 |
| 2022-12-31 | $1.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-28 | -$4.00K derived: sum of 2 quarters · filed 2024-03-28 | -$5.00K derived: sum of 3 quarters · filed 2024-03-28 | -$18.00K 10-K · filed 2024-03-28 |
| 2022-09-30 | -$5.00K 10-Q · filed 2023-11-13 | -$6.00K derived: sum of 2 quarters · filed 2023-11-13 | -$19.00K 10-Q · filed 2023-11-13 | -$24.00K derived: sum of 4 quarters · filed 2023-11-13 |
| 2022-06-30 | -$1.00K 10-Q · filed 2023-08-14 | -$14.00K 10-Q · filed 2023-08-14 | -$19.00K derived: sum of 3 quarters · filed 2023-08-14 | -$23.00K derived: sum of 4 quarters · filed 2023-08-14 |
| 2022-03-31 | -$13.00K 10-Q · filed 2023-05-15 | -$18.00K derived: sum of 2 quarters · filed 2023-05-15 | -$22.00K derived: sum of 3 quarters · filed 2023-05-15 | |
| 2021-12-31 | -$5.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-29 | -$9.00K derived: sum of 2 quarters · filed 2023-03-29 | -$9.00K 10-K · filed 2023-03-29 | |
| 2021-09-30 | -$4.00K 10-Q · filed 2022-11-14 | -$4.00K 10-Q · filed 2022-11-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ATOSSA THERAPEUTICS, INC. (ATOS) | United States | $0.021B | -0.52 |
| ARTELO BIOSCIENCES, INC. (ARTL) | United States | $0.023B | |
| Neuphoria Therapeutics Inc. (NEUP) | United States | $0.020B | -1.77 |
| Marker Therapeutics, Inc. (MRKR) | United States | $0.020B | -2.86 |
| Cellectar Biosciences, Inc. (CLRB) | United States | $0.020B | -1.03 |
| Shuttle Pharmaceuticals Holdings, Inc. (SHPH) | United States | $0.019B | -0.31 |
| TherapeuticsMD, Inc. (TXMD) | United States | $0.024B | -117.87 |
| NextCure, Inc. (NXTC) | United States | $0.024B | -0.15 |
| Rocket One Inc. (RKTO) | United States | $0.019B | |
| AYTU BIOPHARMA, INC (AYTU) | United States | $0.025B | -1.62 |